BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 28, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 11, 2009
View Archived Issues
Ipilimumab shows antitumor activity in phase I trial in relapsed/refractory B-cell lymphoma
Read More
GSK and Valeant file NDA with FDA and MAA with EMEA for retigabine in epilepsy
Read More
Midodrine can reverse anejaculation
Read More
Long-lasting responses to VB4-845 seen in patients with bladder cancer
Read More
Vicor presents update on its activities during first nine months of 2009
Read More
Poly-ICLC combined with dendritic cell vaccine in phase I/II glioma trial
Read More
Bristol-Myers Squibb CB1 antagonists reduce weight in obesity models
Read More
New CB2 agonists active in chronic pain models reported by Neuroscienze PharmaNess
Read More
Chugai reports results from third quarter of 2009
Read More
Chugai's Avastin approved in Japan for additional indication in NSCLC
Read More
Johns Hopkins to host clinical study of Cel-Sci's LEAPS-H1N1 therapy
Read More
Data from 2 clinical trials support safety and efficacy of roflumilast in COPD therapy
Read More
Imatinib mesylate to be evaluated in phase III trial for PAH therapy
Read More
Histamine H4 receptor ligands for the treatment of pain in development at Abbott
Read More
Chiba University discovers novel oncolytic compounds
Read More
Takeda claims Smo receptor antagonists as oncolytics
Read More
Genervon identifies MNTF-derived peptides for neurodegenerative disorders
Read More
Xoma initiates phase II trial of XOMA-052 IL-1beta antibody in type 1 diabetes
Read More
FDA accepts and grants priority review to ChemGenex's NDA for Omapro in CML
Read More
Mologen seeks approval of phase I/II clinical trial of MGN-1601 in renal cancer
Read More
MorphoSys' phase Ib/IIa trial of MOR-103 in RA approved in Germany
Read More
FDA grants orphan drug status to Abraxane for pancreatic cancer and melanoma
Read More
AlphaVax progresses its prophylactic HSV vaccine
Read More
Biovitrum and Swedish Orphan merge to form Swedish Orphan Biovitrum
Read More
Astex signs CRADA with the NCI for anticancer HSP 90 inhibitor AT-13387
Read More
Spectrum and Nippon Kayaku enter collaboration for apaziquone in Asia
Read More
